Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of COVID-19 vaccines in SLE and rheumatoid arthritis patients
TCTR20210917003Active, not recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jun 2021
- Countries
- 1
01
Overview
Trial in coronavirus disease 2019 (COVID-19), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Immunogenicity of COVID-19 vaccines and Safety of COVID-19 vaccines. Started Jun 2021; status: active, not recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210917003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210917003.